| Any stage | Transmural | Overall |
---|
Biomarker | Youden index | Biomarker | Youden index | Biomarker | Youden index |
---|
1 | IMA | 0.85 | I-FABP urine | 0.77 | IMA * | 0.85 |
2 | IL-6 | 0.82 | IL-6 | 0.73 | IL-6 # | 0.79 |
3 | PCT | 0.68 | D-dimer | 0.71 | I-FABP urine | 0.67 |
4 | I-FABP serum | 0.63 | I-FABP serum | 0.68 | PCT | 0.67 |
5 | alpha-GST | 0.61 | PCT | 0.62 | I-FABP serum | 0.64 |
6 | CRP | 0.60 | CRP | 0.56 | alpha-GST * | 0.61 |
7 | I-FABP urine | 0.58 | L-lactate | 0.50 | D-dimer | 0.60 |
8 | D-dimer | 0.57 | D-lactate | 0.38 | CRP | 0.58 |
9 | NLR | 0.54 | WBC | 0.37 | D-lactate | 0.55 |
10 | D-lactate | 0.50 | LDH | 0.34 | NLR | 0.47 |
11 | Citrulline | 0.46 | PLR | 0.31 | Citrulline * | 0.46 |
12 | L-lactate | 0.42 | pH | 0.18 | L-lactate | 0.44 |
- Alpha-GST—alpha glutathione S transferase (alpha-GST); CRP—C-reactive protein; I-FABP—intestinal fatty acid-binding protein; IL-6—interleukin 6; IMA—ischaemia-modified albumin; LDH—lactate dehydrogenase; NLR—neutrophil–lymphocyte ratio; PCT—procalcitonin; PLR—platelet–lymphocyte ratio; WBC—white blood cell count
- Any stage—studies assessing different stages of AMI, including but not limited to non-transmural and transmural; Transmural—studies assessing transmural AMI, with control group including non-transmural AMI; Overall—all studies pooled independent of stage and type of AMI
- *No study on transmural acute mesenteric ischaemia of any type
- #No study on non-occlusive mesenteric ischaemia